ARE Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

742.64M

-5.87%

0.277

-173.01%

693.70M

-8.5%

0.210

-400%

677.17M

-11.14%

-0.130

-79.69%

Estimates Revision

The market is revising Downward the revenue expectations for Alexandria Real Estate Equities, Inc. (ARE) for FY2025, with the revenue forecasts being adjusted by -0.16% over the past three months. During the same period, the stock price has changed by -27.49%.

Revenue Estimates for FY2025

Revise Downward

-0.16%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-670.22%

In Past 3 Month

Stock Price

Go Down

-27.49%

In Past 3 Month

12 Analyst Rating

Wall Street analysts forecast ARE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARE is 64.78 USD with a low forecast of 30.00 USD and a high forecast of 104.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

9 Hold

1 Sell

Hold

Current: 0.000

Low

30.00

Averages

64.78

High

104.00

Current: 0.000

Low

30.00

Averages

64.78

High

104.00

Morgan Stanley

Equal Weight

initiated

$55

2026-01-09

New

Reason

Morgan Stanley

Price Target

$55

2026-01-09

New

initiated

Equal Weight

Reason

Morgan Stanley initiated coverage of Alexandria Real Estate with an Equal Weight rating and $55 price target. The company's portfolio has notably outperformed the market average but has not been immune to occupancy declines, the analyst tells investors in a research note. The firm sees limited earnings visibility for Alexandria.

Cantor Fitzgerald

Neutral

downgrade

$48 -> $46

2026-01-05

New

Reason

Cantor Fitzgerald

Price Target

$48 -> $46

2026-01-05

New

downgrade

Neutral

Reason

Cantor Fitzgerald lowered the firm's price target on Alexandria Real Estate to $46 from $48 and keeps a Neutral rating on the shares. U.S. equity REITs returned 2.9% in 2025, lagging the S&P 500, but 2026 may offer optimism with a potentially more supportive macro environment and an accelerating M&A theme, the analyst tells investors in a research note. Stable supply and demand fundamentals, balance sheet strength, and a well-covered, growing 4% dividend yield make the sector attractive despite past underperformance, Cantor adds.

Deutsche Bank

Omotayo Okusanya

Hold

downgrade

$83 -> $45

2025-12-19

Reason

Deutsche Bank

Omotayo Okusanya

Price Target

$83 -> $45

2025-12-19

downgrade

Hold

Reason

Deutsche Bank analyst Omotayo Okusanya lowered the firm's price target on Alexandria Real Estate to $45 from $83 and keeps a Hold rating on the shares. The firm reduced estimates following the company's investor day. Alexandria's outlook "has materially worsened" as the full impact of the weak biotech real-estate demand/supply fundamentals makes its way through the company's earnings outlook, the analyst tells investors in a research note.

Jefferies

Hold

downgrade

$62 -> $47

2025-12-15

Reason

Jefferies

Price Target

$62 -> $47

2025-12-15

downgrade

Hold

Reason

Jefferies lowered the firm's price target on Alexandria Real Estate to $47 from $62 and keeps a Hold rating on the shares as part of a broader research note previewing 2026 for Healthcare REITs. The firm expects another challenging year for lab landlords as elevated market vacancy and a 9.6% decline in trailing-12-month biotech funding will drive below-average retention in 2026, the analyst tells investors in a research note. Landlords have limited negotiating leverage, and the firm's market forecast suggests this will persist for several years, Jefferies added.

Cantor Fitzgerald

Neutral

downgrade

$52 -> $48

2025-12-05

Reason

Cantor Fitzgerald

Price Target

$52 -> $48

2025-12-05

downgrade

Neutral

Reason

Cantor Fitzgerald lowered the firm's price target on Alexandria Real Estate to $48 from $52 and keeps a Neutral rating on the shares. The firm says the company's investor day was titled a "reset" for a company slugging through dam-breaking fundamental headwinds created by extreme levels of oversupply and still tepid demand for lab space. Cantor thinks the company came to the event with appropriate humility and an open book of what lies ahead, which for now isn't pretty.

BofA

Joshua Dennerlein

Neutral

downgrade

$57 -> $50

2025-12-05

Reason

BofA

Joshua Dennerlein

Price Target

$57 -> $50

2025-12-05

downgrade

Neutral

Reason

BofA analyst Joshua Dennerlein lowered the firm's price target on Alexandria Real Estate to $50 from $57 and keeps a Neutral rating on the shares after the company hosted its investor day this week. Management now expects the overall life science market to take 4-5 years to reach equilibrium, versus prior forecasts of 2-3 years, and Alexandria reduced the high end of its FY26 guidance that was initially provided with Q3 earnings, the analyst noted.

Valuation Metrics

The current forward P/E ratio for Alexandria Real Estate Equities Inc (ARE.N) is 211.17, compared to its 5-year average forward P/E of 53.66. For a more detailed relative valuation and DCF analysis to assess Alexandria Real Estate Equities Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

53.66

Current PE

211.17

Overvalued PE

87.89

Undervalued PE

19.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

20.71

Current EV/EBITDA

15.16

Overvalued EV/EBITDA

24.71

Undervalued EV/EBITDA

16.70

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

8.18

Current PS

3.04

Overvalued PS

11.26

Undervalued PS

5.09

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ARE News & Events

Events Timeline

No data

News

9.5

01-08Yahoo Finance

PinnedAecon Group Schedules Q4 and Year-End 2025 Financial Results Release

7.0

01-09PRnewswire

Alexandria Real Estate Equities Faces Class Action Lawsuit with No Out-of-Pocket Costs for Investors

7.0

01-09Globenewswire

Alexandria Real Estate Faces Class Action for Misleading Statements

People Also Watch

Frequently Asked Questions

What is Alexandria Real Estate Equities Inc (ARE) stock price today?

The current price of ARE is 53.97 USD — it has increased 1.31 % in the last trading day.

What is Alexandria Real Estate Equities Inc (ARE)'s business?

Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.

What is the price predicton of ARE Stock?

What is Alexandria Real Estate Equities Inc (ARE)'s revenue for the last quarter?

Alexandria Real Estate Equities Inc revenue for the last quarter amounts to 786.73M USD, decreased -3.42 % YoY.

What is Alexandria Real Estate Equities Inc (ARE)'s earnings per share (EPS) for the last quarter?

Alexandria Real Estate Equities Inc. EPS for the last quarter amounts to -1.38 USD, decreased -243.75 % YoY.

What changes have occurred in the market's expectations for Alexandria Real Estate Equities Inc (ARE)'s fundamentals?

How many employees does Alexandria Real Estate Equities Inc (ARE). have?

Alexandria Real Estate Equities Inc (ARE) has 552 emplpoyees as of January 10 2026.

What is Alexandria Real Estate Equities Inc (ARE) market cap?

Today ARE has the market capitalization of 9.33B USD.